- $6.59bn
- $6.78bn
- $4.39bn
- 96
- 61
- 73
- 91
2019 October 31st | 2020 October 31st | 2021 October 30th | 2022 October 29th | 2023 October 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,572 | 3,532 | 3,621 | 3,633 | 4,387 |
Cost of Revenue | |||||
Gross Profit | 1,542 | 1,653 | 1,715 | 1,560 | 1,879 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,225 | 3,046 | 3,125 | 3,410 | 4,037 |
Operating Profit | 347 | 486 | 495 | 223 | 350 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 313 | 456 | 463 | 183 | 324 |
Provision for Income Taxes | |||||
Net Income After Taxes | 253 | 361 | 500 | 153 | 255 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 253 | 361 | 500 | 153 | 255 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 253 | 361 | 500 | 153 | 255 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.75 | 2.46 | 3.15 | 1.19 | 1.89 |